Fri, Jul 3, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

State Street takes the pulse of buy-side firms mandated to clear OTC Derivatives

Wednesday, July 31, 2013

Bailey McCann, Opalesque New York:

Buy-side firms are unprepared for new trading mechanisms, costs and increased complexity in the OTC market according to new research commissioned by State Street Corporation. The findings show that buy-side firms may need to work more proactively with providers meet challenges imposed by regulatory changes. The paper – "From Readiness to Revolution: The Implementation and Impact of Derivatives Clearing Regulatory Reform," explains how firms will have to prepare for swap execution facilities (SEFs), central clearing, collateral management and reporting.

State Street already serves as a futures clearing merchant (FCM) and a SEF. The paper highlights developments across the entire trade life-cycle and includes a roadmap to readiness for Category III firms – those firms that have yet to complete the Commodity Futures Trading Commission’s (CFTC) phased implementation of Derivatives clearing.

Changes in the OTC Derivatives requirements have created three types of firms – Categories I, II and III. Category I firms are companies that have completed the transition to mandated clearing. According to the paper, firms that meet this criteria and acted early have had the opportunity to negotiate more advantageous FCM agreements.

Category II firms have also met those requirements but because they were slower to act, found FCMs less willing to negotiate on terms. Category III fi......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner